Projecten
Molecular epidemiological approach to understand the emergence and spread of drug resistant Mycobacterium tuberculosis strains in Peru Instituut voor Tropische Geneeskunde
Improving detection of drug-resistant tuberculosis (TB by use of novel phenotypic and genotypic tests Instituut voor Tropische Geneeskunde
Development of a two-approach plate system for the fast and simultaneous detection of MDR and XDR M. tuberculosis Instituut voor Tropische Geneeskunde
Tuberculosis (TB) continues being a leading cause of death due to a single infectious disease agent. The HIV/AIDS pandemic and the emergence of drug resistance are compounding factors that hinder the control of the disease. Associated with this problem is the emergence of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, defined as strains resistant to at least isoniazid and rifampicin, the most valuable drugs in the treatment ...
Studies on multidrug resistance tuberculosis in Rwanda: Turning off the tap Instituut voor Tropische Geneeskunde
In this PhD proposal, we intend to document the impact of PMDT interventions on the diagnostic- and treatment delays, and the resulting genotypic clustering of MDR-TB over a ...
Utilization of molecular resistance test results as tools to support public health efforts for improved control of rifampicin resistant tuberculosis Instituut voor Tropische Geneeskunde
Molecular characterization of mycobacterial strains from clinical specimens of patients with tuberculosis Instituut voor Tropische Geneeskunde
Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating More Instituut voor Tropische Geneeskunde
Centrum voor whole genomen sequencing van Mycobacterium tuberculosis Universiteit Antwerpen
Pan-European network for the study and clinical management of drug resistant tuberculosis Instituut voor Tropische Geneeskunde
Establishment of an integrated and synergistic network to address the challenge of multiple drug resistant TBC (MDR-TB) facing the EU. The objective will be attained through the establishment of a European consortium of expert partners with extensive experience in the conduct of basic and clinical research relating to MDR-TB, TB control and epidemiology. This Consortium will achieve this by:
Conducting an extensive and focused programme of ...